CompletedPhase 2

Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia

Zambia66 participantsStarted 2008-11

Plain-language summary

In this study, 66 HIV-infected women who desire contraception will be randomly assigned to use either an IUD or Depo Provera, and will be followed for six months. The study is intended to help investigators understand potential mechanisms by which hormonal contraception may hasten HIV disease progression.

Who can participate

Age range16 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed HIV status by local rapid test algorithm * Willingness to be randomized to a contraceptive method and continue that method for at least 6 months. * Intention to stay in the study area for at least 6 months Exclusion Criteria: * Currently pregnant or pregnant within the prior 6 months * Currently breastfeeding * Documented liver disease * History of coagulation disorder * Active tuberculosis * Anemia, defined as Hgb \<8gm/dL * Age \< 16 years (the age of consent in Zambia); * Eligible for antiretroviral therapy based on Zambian National Guidelines (CD4+ \< 200, or WHO stage IV, or CD4+\< 350 and WHO stage III) * Currently using an IUD or hormonal method of contraception, or have used a hormonal contraceptive in the past 6 months

What they're measuring

T-cell activation

Timeframe: 4, 8, 12, and 24 weeks post-randomization

Trial details

NCT IDNCT00807625

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-07

View on ClinicalTrials.gov More HIV trials